Literature DB >> 26755863

Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.

Francesco Agnello1, Marco Dioguardi Burgio1, Dario Picone1, Federica Vernuccio1, Giuseppe Cabibbo1, Lydia Giannitrapani1, Adele Taibbi1, Antonino Agrusa1, Tommaso Vincenzo Bartolotta1, Massimo Galia1, Roberto Lagalla1, Massimo Midiri1, Giuseppe Brancatelli1.   

Abstract

Gadoxetic acid improves detection and characterization of focal liver lesions in cirrhotic patients and can estimate liver function in patients undergoing liver resection. The purpose of this article is to describe the optimal gadoxetic acid study protocol for the liver, the unique characteristics of gadoxetic acid, the differences between gadoxetic acid and extra-cellular gadolium chelates, and the differences in phases of enhancement between cirrhotic and normal liver using gadoxetic acid. We also discuss how to obtain and recognize an adequate hepatobiliary phase.

Entities:  

Keywords:  Cirrhosis; Gadoxetic acid; Hepatobiliary contrast materials; Liver; Magnetic resonance imaging

Mesh：

Substances：

Year:  2016        PMID： 26755863      PMCID： PMC4698478          DOI： 10.3748/wjg.v22.i1.103

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  59 in total

1.  Significance of the "delayed hyperintense portal vein sign" in the hepatobiliary phase MRI obtained with Gd-EOB-DTPA.

Authors:  Nam Kyung Lee; Suk Kim; Gwang Ha Kim; Jeong Heo; Hyung Il Seo; Tae Un Kim; Dae Hwan Kang
Journal:  J Magn Reson Imaging       Date:  2012-05-30       Impact factor: 4.813

2.  Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging.

Authors:  Mustafa R Bashir; Elmar M Merkle
Journal:  Eur Radiol       Date:  2010-08-05       Impact factor: 5.315

3.  Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers.

Authors:  Tsutomu Tamada; Katsuyoshi Ito; Teruki Sone; Akihiko Kanki; Tomohiro Sato; Hiroki Higashi
Journal:  Eur J Radiol       Date:  2010-09-24       Impact factor: 3.528

Review 4.  Primovist, Eovist: what to expect?

Authors:  Bernard E Van Beers; Catherine M Pastor; Hero K Hussain
Journal:  J Hepatol       Date:  2012-04-12       Impact factor: 25.083

5.  Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection?

Authors:  Hiroki Haradome; Luigi Grazioli; Khalid Al manea; Mika Tsunoo; Utaroh Motosugi; Thomas C Kwee; Taro Takaraha
Journal:  J Magn Reson Imaging       Date:  2011-09-29       Impact factor: 4.813

6.  Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.

Authors:  Tsutomu Tamada; Katsuyoshi Ito; Atsushi Higaki; Koji Yoshida; Akihiko Kanki; Tomohiro Sato; Hiroki Higashi; Teruki Sone
Journal:  Eur J Radiol       Date:  2011-02-18       Impact factor: 3.528

7.  Clinical significance of the transitional phase at gadoxetate disodium-enhanced hepatic MRI for the diagnosis of hepatocellular carcinoma: preliminary results.

Authors:  Yuko Nakamura; Naoyuki Toyota; Shuji Date; Seitaro Oda; Tomohiro Namimoto; Yasuyuki Yamashita; Toru Beppu; Kazuo Awai
Journal:  J Comput Assist Tomogr       Date:  2011 Nov-Dec       Impact factor: 1.826

8.  Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging.

Authors:  Atsushi Higaki; Tsutomu Tamada; Teruki Sone; Akihiko Kanki; Tomohiro Sato; Daigo Tanimoto; Hiroki Higashi; Katsuyoshi Ito
Journal:  Magn Reson Imaging       Date:  2012-03-27       Impact factor: 2.546

9.  The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study.

Authors:  Seung Hyun Cho; Ung Rae Kang; Joo Dong Kim; Young Seok Han; Dong Lak Choi
Journal:  Eur J Radiol       Date:  2011-09-09       Impact factor: 3.528

10.  MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation.

Authors:  C S van Kessel; W B Veldhuis; M A A J van den Bosch; M S van Leeuwen
Journal:  Eur Radiol       Date:  2012-05-30       Impact factor: 5.315
View more
  3 in total

1.  Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.

Authors:  Claudia Khouri Chalouhi; Federica Vernuccio; Francesca Rini; Piergiorgio Duca; Bruno Tuscano; Giuseppe Brancatelli; Angelo Vanzulli
Journal:  Eur Radiol       Date:  2018-12-13       Impact factor: 5.315

2.  Lipase hypersecretion syndrome: A rare cutaneous manifestation of advanced pancreatic acinar cell carcinoma.

Authors:  Wasay Nizam; Adil A Shah; Fareed Rajack; Asa Ramdath; Tammey Naab; Mallory Williams
Journal:  Clin Case Rep       Date:  2020-03-12

Review 3.  Advances in liver US, CT, and MRI: moving toward the future.

Authors:  Federica Vernuccio; Roberto Cannella; Tommaso Vincenzo Bartolotta; Massimo Galia; An Tang; Giuseppe Brancatelli
Journal:  Eur Radiol Exp       Date:  2021-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.